|
| 南模生物(688265)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2025-06-27 | 2857.50 | 36.65% | 7796.35 | 0.00 | 4938.85 | 63.35% | 追加承诺限售股份上市流通 | | 2023-12-28 | 70.91 | 0.91% | 4938.85 | 2857.50 | 4883.58 | 62.64% | 首发战略配售股份 | | 2022-12-28 | 3022.16 | 38.76% | 4867.95 | 2928.41 | 4867.95 | 62.44% | 首发原股东限售股份,首发战略配售股份 | | 2022-06-28 | 83.46 | 1.07% | 1948.49 | 5847.86 | 1948.49 | 24.99% | 首发机构配售股份 | | 2021-12-28 | 1762.33 | 22.60% | 1762.33 | 6034.02 | 1762.33 | 22.60% | 首发一般股份 |
|